MULTIMODAL, PREEMPTIVE AND NEXT-GEN ANALGESIA WITH JR PHILLIPS | EP55
Description
This episode of the Atomic Anesthesia Podcast explores the emerging role of Suzetrigine, a novel non-opioid NaV1.8 channel inhibitor, in multimodal surgical pain management. Host Rhea and guest JR Phillips, a DNAP student, discuss the science, efficacy, and safety profile of Suzetrigine, its potential for opioid-sparing strategies, and its unique advantages over traditional opioids and sodium channel blockers. Listen in for an evidence-based look at how this new FDA-approved analgesic could reshape perioperative care, improve patient outcomes, and what its current limitations and future possibilities might be for anesthesia professionals and learners.
To take a quiz about this topic, check out this link: [HERE]
For references for this episode, click [HERE]
Want to learn more? Create a FREE account at www.atomicanesthesia.com
⚛️ CONNECT:
🩷 Subscribe to our YouTube channel
📥 Have a topic you want to hear? Email Dr. Temmermand at hello@atomicanesthesia.com
United States
